Hydrochlorthiazide

Hydrochlorthiazide

SCHEMBL17201627

CC(C)(C)OC(=O)c1nccs1.c1cscn1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
RBBP9 O75884 5/20 0.36
CYP1A2 P05177 4/20 0.35
CYP2C19 P33261 4/20 0.35
CYP2D6 P10635 3/20 0.35
CASP3 P42574 2/20 0.35
SENP8 Q96LD8 2/20 0.35
SENP7 Q9BQF6 2/20 0.35
SENP6 Q9GZR1 2/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
METAP1 P53582 1/20 0.34
GPR119 Q8TDV5 1/20 0.32
CYP2C9 P11712 1/20 0.32
PLA2G4A P47712 1/20 0.31
HPGDS O60760 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201513 0.88 ALDH1A1 (0.55) ALDH1A1RBBP9CYP1A2CYP2C19CYP2D6
Hydrochlorthiazide SCHEMBL9109786 0.79 ALDH1A1 (0.72) ALDH1A1RBBP9CYP1A2CYP2C19CYP2D6
Hydrochlorthiazide SCHEMBL15798726 0.79 ALDH1A1 (0.72) ALDH1A1RBBP9CYP1A2CYP2C19CYP2D6
Hydrochlorthiazide SCHEMBL27757215 0.73
SCHEMBL27531002 0.72 ALDH1A1 (0.50) ALDH1A1RBBP9CYP1A2CYP2C19CYP2D6
SCHEMBL1009292 0.69
SCHEMBL28662188 0.69 METAP1 (0.50) ALDH1A1RBBP9CASP3SENP8SENP7
SCHEMBL28662185 0.69 ALDH1A1 (0.47) ALDH1A1RBBP9CYP1A2CYP2C19CYP2D6
SCHEMBL23727257 0.68 ALDH1A1 (0.46) ALDH1A1RBBP9CYP1A2CYP2C19CYP2D6
SCHEMBL109510 0.68 METAP1 (0.46) ALDH1A1RBBP9CASP3SENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT ALDH1A1 886/4885RBBP9 3599/4885CYP1A2 1458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.